DIM DDC4IRAE. A METHOD 70'( DETE1RNTNING THE- CONCENTRATTOIN 01' -Kil UD PERTUSSIS VACCINE TN THEF AIRP TRANSLATION NO

Similar documents
N. A STUDY OF THE VIRULENCE OF THE BRUCELLA VACCINE STRAIN

\Ail AN EXPERIMENTAL STUDY OF SIMULTANEOUS VACCINATION AGAINST TULAREMIA AND TUBERCULOS Translation No./1449. May 1966

DDC DATE: TRANSLATION NO. 9 DDC AVAILABILITY NOTICE. Qualified requestors may obtain copies of this document from DXC.

HiAD tply7 0$1CROFRnE, $4

N ~~Translation No. f'

r ~DETECTION OF THE MINIMUM CONCENTRATIONS OF INFLUENZA VIRUS IN THE DROPLET PHASE OF AN AEROSOL

Ma-, 1966 fj U. S. ARMY BIOLOGICAL LABCRATORIES FORT DETRICK, FREDERICK, MARYLAND

Best Available Copy. THE EFFECTIVENESS OF IMMUNIZATION THROUGH SCARIFIED SKIN )fith THE LIVE PLAGUE VACCINE. Translation No.

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

"I FORT DF.TRICK, FREDERICK, MARYLAND D DDGC_ IN SAILORS SMALLPOX IMMUNITY. Translation, No. 91stlillbution of This Document Is Unlhl

MENEM GO& DDC MAR '

S46 \APPLICATTON OF TIM. STATTSTICAL METIIOI) IN Tlh.'UwIx OF

NEW ONE-STAGE PROCEDURES FOR THE QUANTITATIVE DETERMINATION OF PROTHROMBIN AND LABILE FACTOR*

Laboratory Procedure Handout RHEUMATOID FACTORS

DEPARTMENT OF T.E ARMY Fort Detrick Frederick, Maryland

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

INFECTIOUS ALLERGY ARMY BIOLOGICAL LABORATOIKNIE F ORT DETRICK, FREDERICK, MARY.AN. TRANSLATION NO. November i6ltbi".ii.

MIXED XYLANASE, β-glucanase ENZYME PREPARATION, produced by a strain of HUMICOLA INSOLENS

U. S. ARM I, ' THE USE OF HIGUCHI-SMITH MEDIUM FOR IMPROVING THE IMMUNOGENIC PROPERTIES OF PLAGUE VACCINE STRAINS

Global Histone H3 Acetylation Assay Kit

Purity Tests for Modified Starches

MycoBlue TM Mycoplasma Detector

Galactose and Lactose Assay Kit

Protease Assay. (Cat. # ) think proteins! think G-Biosciences

االستاذ المساعد الدكتور خالد ياسين الزاملي \مناعة \المرحلة الثانية \ التحليالت المرضية \ المعهد التقني كوت

RayBio DPP4 Inhibitor Screening Kit

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA

The following protocol describes the isolation of nuclei from tissue. Item. Catalog No Manufacturer

AD THE CULTIVATION OF VIRUSES OF THE TICK-BORNE ENCEPH- ALITIS GROUP ON MONKEY-HEART CELLS. L. G. Karpovich, et al

J07 Titer dynamics, complement fixation test and neutralization tests

RayBio Annexin V-Cy5 Apoptosis Detection Kit

Taenia solium IgG ELISA Kit

TRANSLATION NO.2-0?e DATE:.(/- DDC AVAILABILITY NOTICE. Qualified requestors may obtain copies of this document from DDC.

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

(From the Department of Pathology, New York University, School of Medicine, and The Rockefeller Institute, New York)

BHARAT SEVAK SAMAJ NATIONAL DEVELOPMENT AGENCY, PROMOTED BY GOVERNMENT OF INDIA MEDICAL LABORATORY TECHNICIAN ONE YEAR COURSE EXAMINATION

The term complement refers to the ability of a system of some nonspecific proteins in normal human serum to complement, i.e., augment the effects of

WHEN DOES BLOOD HAEMOLYSE? A Temperature Study

Enzymatic Assay of POLYGALACTURONASE (EC )

Core practical 1: Investigate how enzyme concentration affects the initial rate of an enzyme-controlled reaction

Pandemic Preparedness Team Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention USA VERSION 1

TRACP & ALP Assay Kit

Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

Hepatitis A virus IgM ELISA Kit

BACTERIAL PATHOGENESIS

Complement Pathway Function

Branched Chain Amino Acid (Leu, Ile, Val) Assay Kit

IVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.

22 Bicozamycin (Bicyclomycin)

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

Complement. Definition : series of heat-labile serum proteins. : serum and all tissue fluids except urine and CSF

Third line of Defense

Blood consists of red and white blood cells suspended in plasma Blood is about 55% plasma and 45% cellular elements Plasma 90% water 10% dissolved

Enzyme Analysis using Tyrosinase. Evaluation copy

Mouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev.

EPIGENTEK. EpiQuik Global Histone H3 Acetylation Assay Kit. Base Catalog # P-4008 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

β-carotene-rich Extract From Dunaliella Salina

ESS Method 310.2: Phosphorus, Total, Low Level (Persulfate Digestion)

FACTORS INVOLVED IN THE USE OF ORGANIC SOLVENTS AS PRECIPITATING AND DRYING AGENTS OF IMMUNE SERA BY MALCOLM H. MERRILL ni~ MOYER S.

Campylobacter Antigen ELISA Kit

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

EPIGENTEK. EpiQuik Global Histone H4 Acetylation Assay Kit. Base Catalog # P-4009 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EpiQuik Circulating Acetyl Histone H3K18 ELISA Kit (Colorimetric)

PARATEST STABILITY STUDY, SYSTEM USED FOR DIAGNOSIS OF INTESTINAL PARASITES

EXOTESTTM. ELISA assay for exosome capture, quantification and characterization from cell culture supernatants and biological fluids

Treponema pallidum immune adherence test for

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Comparative Evaluation of Five Serological Methods for the Diagnosis of Sporotrichosis

For questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2

Acetyl-CoA Assay Kit. Catalog Number KA assays Version: 04. Intended for research use only.

Glutathione Assay Kit

Total Bilirubin Assay Kit Manual Catalog #:

ab Lipid Peroxidation (MDA) Assay kit (Colorimetric/ Fluorometric)

Heparan Sulfate ELISA Kit (Cat: No )

RayBio Phenylalanine Fluorometric Assay Kit

Vitamin C Assay Kit. ( DNPH method )

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

RICINOLEATE UPON BACTERIA

H. pylori Antigen ELISA Kit

AD THE USE OF A SOLUBLE ANTIGEN OF 'RICKETTSIA BURNETI' AS AN ALLERGEN FOR DIAGNOSIS OF FRESH CASES OF Q-FEVER IN MAN

[388] COUNTING SPERMATOZOA

Coenzyme A Assay Kit. Catalog Number KA assays Version: 02. Intended for research use only.

Determination of Copper in Green Olives using ICP-OES

Mouse C3 (Complement Factor 3) ELISA Kit

RayBio Maltose and Glucose Assay Kit

Lutein Esters from Tagetes Erecta

Mouse C-Peptide ELISA Kit

The % of blood consisting of packed RBCs is known as the hematocrit. Blood s color ranges from scarlet (oxygen-rich) to dark red (oxygen poor).

Human TSH ELISA Kit. User Manual

1.2 Systematic Name: Orthophosphoric-monoester phosphohydrolase (alkaline optimum)

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature

Rubella Latex Agglutination Test

Case Log Number(s) Veterinarian or VTS Accurately report test results, using appropriate units of measurement Quality Control/Assurance Date Mastered

HBeAg and HBeAg Ab ELISA Kit

ABIOpure TM Viral (version 2.0)

Lipid Droplets Fluorescence Assay Kit

DDC AVAILABILITY NOTICE DEPART O ARIYII. Thia do n z,, c, DEPARTMENT OF THE ARMY Fort Detrick Frederick, Maryland

Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples:

Transcription:

Xký A METHOD 70'( DETE1RNTNING THE- CONCENTRATTOIN 01' -Kil UD PERTUSSIS VACCINE TN THEF AIRP TRANSLATION NO. 1051 DIM DDC4IRAE e U~~INI I IJ) ~II ' Fort Oc tyj(k, PrelcIrick.

Translated by Sp/6 Charics T. Ostertag, Jr. Transiation No. 1051 t DDC AVAILABILITYt NTICE (ralified requestors may obtain copies of' this document from DDC. This publication has been translated from the open literature and is available to the general public. Non-DOD agencies may purchase this publication from Clearinghouse for Federal Scientific and Technical information, U. S. Department of Commerce, Springfield, Va. T echnical Library 3--n-h?echnical laformtion.ivisiorn

4 A METOD FOR DETERMIANIN THE CONC ITRATITN OF KILLED PERTUSSIS VACCINE IN THE AIR [Following is a translation of an article by F. G. Mayorova, Gamaleya Institute of Epidemiology and Microbiology, AMN, USSR, published in the Russit2-language periodical Zhurnal Mikrobiologii Epidemiologii i bmunobiologii (Josurnal of Microbiology, Epidemiology, and Immunobiology) 1963, No 11, pages 65-69. It was received on 2 Mar 63. Translation performed by Sp/6 Charles T. Ostertag Jr.] One of the necessary conditions for utilizing the inhalation method of immunization is the presence of a method for determining the concentration of vaccine in the air and the inhaled dose. Since under these conditions of work it is necessarl to deal with low concentrations of antigen, the method for determining it should be highly sensitive. The mission of the present work is developing a method for determining killed pertussis vaccine in the air. With this aim an attempt has been made to use the complement fixation reaction in the classic arrangement. Immune rabbit antipertussia serum produced by the Moscow Institute of Microbiology, Epidemiology, and Hygiene was used for the reaction. Before the experiment the serum was warmed for 30 mtnutes at 560 (inactivation of complement) and its wor'-ing dilutions prepared in a physiological solution (1:50 or 1:70). The complement was titrated before the experiment and taken in the amount of 1.5 and 2 units (as a unit of complement we accepted that samunt of it which was necessary for the lysis of an 0.01% suspension of erythrocytes in 0.25 ml mixed with 0.25 ml of a threefold titer of hemolysin). The vaccine from pertussis bacteria phase I which are formalin killed served as the antigen. The reaction was taken into consideration after it was carried out in control test tubes and was considered as positive with a clear impediment of hemolysis (4++ and +4+-). The complement fixation reaction turned out to be suitable for the quantitative determination of pertussis vaccine in low concentrations. As an example, we will present the results of one experiment (table 1) which : 1

showed that in this it was possible to expose 250-312, 250-500 million microbial cells in 1 ml of suspension. The specified fluctuations were apparently caused by the lability of the biological components of the reaction, and maybe by a different calibration of the pipettes. In this, it turned out that in the reactiiv it was more advantageous to use not 2 but 1.5 units of complement, in the presence of which the reaction was more sensitive. In determining the concentration of pertussis bacilli in each experiment the suspension of vaccine being tested was titrated parallel witi a suspension of vaccine -'t- -ch the concentration of pertussis bacilli was established earlier according to the optical standard (control series). The content of pertussis antigen was computed according to the extreme dilutions which inhibit hemolysis (+++ and 1+++), considering that the concentration of extreme dilutions of the control and test series is equivalent. We will present (table 2) examples of the calculation based on the data from a number of experiments. The computation was carried out in the following manner. It is known that in the control, the pertussis vaccine in the initial concentration, equal to 2 billion microbial cells in 1 ml, was established to a dilution of 1:4, that is to 500 million microbial cells in 1 ml. The test solution reacted down to a dilution of 1:8, or 1:16 or 1:32, etc., consequently 1 ml of test solution contained 500 million X 8=4 billion, or 500 million X 32-16 billion, etc. The results obtained cannot be indicators of the absolute concentration of vaccine, since their deteimination was limited by the indicators of the series of dilutions (1:2, 1:4, 1:8, 1:16, etc.). By reducing the gap between dilutions the difference in the concentrations being exposed can be lowered. With this aim of consolidating and refining the determination of the concentration of pertussis vaccine, we utilized a FEK-M photocolorimeter. For this a graduated curve was constructed which corresponded to the various concentrations of formalinized pertussis (fig. 1). In constructing the graduated curve, suspensions of vaccine were used with a content of from 50 million up to 3 billion of microbial cells in 1 ml based on the pertussis standard. Measuring the optical density of all the suspensions was done with a blue light filter while using a cuvette 2 mm in diameter. Deternining the optical density of a solution of pertussis bacilli of an unknown concentration was performed on the blue light filter. Then, based on the graduated curve the concentration of suspension was found which corresponded to the given optical density. Det..rmining the optical density of the vaccine parallel with setting up the complement fixation reaction verified the correctness of the results. The exposure of the concentration of vaccine based on optical density turned out to be very accurate and reflected small changes in concentrations. In practice, by this method it was puasible to determine a concentration of pertussis vaccine approximstplay down to 50-100 million bacteria in I ml (based on the pertussis standard).

Both methods were used for determining the concentration of an aerosol of pertussis vaccine in the air of an aerosol chamber. The pertussis bacilli were trapped on FPA fibrous tilters with a resistance of 1.5--2 mm water coluwn. The microbial cells were so densely fixed on the fibers that for the complete exposure of all the antigen found on the filter it was dissolved in acetone. The pertussis vaccine was separated out during cen,-ifugation, The centrifugate was maintained in the test tubes for no less than two hours (some times up to the following day) at room temperature until the evaporation of the acetone residue and then suspended in a physiological solution. With this suspension the complement fixation reaction was set up and the concentration of microbial cells was determined by photocolorimetry. It was established that when mixing the acetone with the physiological solution turbidity appeared, therefore it was necessary to carefully watch that after centrifugation the acetone completely evaporated. These manipulations didn't reflect substantially on the pertussis antigen (fig. 2 and 3). After staining the preparations with antiluminescent pertussis serum in a dilution of 1:40 the brightness of luminescence was preserved (++++). The calculation of the concentration of vaccine (K) in 1 ml of air vras carried out by computing the liters of air passing through the filter (V), the dilution in the test series in which the p-rtussis antigen was determined (C), and the final concentration of the control series (A) according to the formula: K=.A. Cý V Calculation of the inhaled dose (D) was carried out by computing the instantaneous lung volume of the subject (m), the concentration of vaccine in 1 liter of air (K), and the coefficient of aerosol inhibition with a value up to 3,# in the respiratory tracts T according to the formula. D - Kmf. CONCLUSIONS 1. The method of the quantitative determination of pertussis bacilli in a suspension with the help of the complement fixation reaction is sufficiently sensitive and reliable. With this method it was possible to expose down to 250-500 million pertussis bacilli in I ml. 2. For determining the concentration of pertussis bacteria in an experiment it is recommended to usc the photocolorimetric method under the control of reactions which expose its specificity. 3. The complement fixation reaction and the photocolorimetric method can be used for determining the concentration of pertussis bacilli in the air of a room and the extent of the inhaled dose of pertussis vaccine. 3

Figure 1. (page 67) Photocolorimeter indicators depending on the concentration of the microbial suspension. a. Photocolorimeter indicators b. Pertussis bacilli c. Intestinal bacilli d. Concentration of microbes (in billions) Figure 2. (page 68) Figure 3. (page 68) Preparation of portussis vaccine retained from the air by a FPA filter. Stained with specific luminescent pertussis serum. Preparation of pertussis vaccine fr,,m the precipitate obtained after dissolving of the FPA filter with acetone. Stained with specific luminescent pcrtussis serum. 4,,